Characterization of the different S6Ks isoforms interacting partners by Isadora Pavan et al.
POSTER PRESENTATION Open Access
Characterization of the different S6Ks isoforms
interacting partners
Isadora Pavan, Flávia Ferreira, Lidia de Freitas, Mariana Tavares, Camila do Amaral, Fernando Simabuco*
From Metabolism, Diet and Disease 2014: Cancer and metabolism
Washington DC, USA. 28-30 May 2014
mTOR signaling pathway has been related to several
human diseases and disorders, including obesity, diabetes
and many types of cancer. In the cell, mTOR signaling is
responsible to induce cell growth and metabolism upon
activation by signals from nutrients processing, such as
insulin, ATP and amino acids. S6Ks, which phosphorylates
ribosomal S6 protein, are effectors of the mTOR pathway.
S6K family is composed of two genes (encoding S6K1 and
S6K2) and different isoforms from alternative translation
initiation (p70-S6K1, p85-S6K1, p54-S6K2, p56S6K2) and
alternative splicing (p31-S6K1). The main function
of S6Ks, upon activation, is to lead increased protein
synthesis. Nevertheless, one of the main questions in this
field is to address the specific roles of the different S6Ks
isoforms. In this study, we overexpressed p70-S6K1,
p85-S6K1 and p54-S6K2 in human cells and analyzed by
immunoprecipitation, followed by mass spectrometry
identification, the different interacting partners of those
S6Ks isoforms. The different roles of S6Ks isoforms were
also evaluated in an adipocyte model and in cancer cell
lines. Our study provide new possible functions to the
different S6Ks isoforms which may help the understanding
of their roles in the mTOR signaling pathway, metabolism
and cancer.
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